Exploring potential biomarkers of diffuse large B-cell lymphoma through multi-dimensional data
{{output}}
Background: Diffuse large B-cell lymphoma (DLBCL) is a clinically and molecularly heterogeneous malignancy with variable outcomes. Identification of reliable biomarkers is critical for risk assessment and targeted therapy. ... ...
